Co-Diagnostics, Inc. (CODX) vs Skye Bioscience, Inc. (SKYE)
A side-by-side comparison of Co-Diagnostics, Inc. and Skye Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CODX
Co-Diagnostics, Inc.
$1.13HealthcareDelayed quote: Oct 6, 2026, 1:57 PM EDT
SKYE
Skye Bioscience, Inc.
$1.66HealthcareDelayed quote: Oct 6, 2026, 2:00 PM EDT
Total return — CODX vs SKYE
growth of $100 · dividends reinvested · last 9yCODX -99.4% (-43.0%/yr)SKYE -99.7% (-47.6%/yr)CODX compounded faster over this window
CODX SKYE
CODX vs SKYE: by the numbers
- •SKYE is the larger company ($7M vs $7M market cap).
- •Both run net losses; SKYE's is the smaller (0.00% vs -6523.04% net margin).
Metrics side by side
Valuation
| Metric | CODX | SKYE |
|---|---|---|
| P/S ratio | 9.75 | N/A |
| P/B ratio | 0.55 | N/A |
Profitability
| Metric | CODX | SKYE |
|---|---|---|
| Gross margin | 64.28% | 0.00% |
| Operating margin | -5025.53% | 0.00% |
| Net margin | -6523.04% | 0.00% |
| ROE | -370.16% | N/A |
| ROIC | -219.15% | N/A |
Growth (annualized)
| Metric | CODX | SKYE |
|---|---|---|
| Revenue CAGR (5Y) | -62.43% | N/A |
| Total return CAGR (5Y) | -66.53% | -60.42% |
Frequently asked
- How have CODX and SKYE total returns compared?
- Over the past 5 years, CODX delivered -66.53% and SKYE delivered -60.42% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.